New Delhi, Mar 07 (UNI) The Union Cabinet today approved the merger of the Central Indian Pharmacopocia Laboratory (CIPL), Ghaziabad with indian Pharmacopoeia Commission (IPC).
The move will help transfer of staff, assets and liabilities including buildings and all other existing infrastructure belongings to the CIPL, Ghaziabad to the control of IPC.
This will also authorise the IPC to make use of the staff and infrastructure of the CIPL, Information and Broadcasting Minister Priaya Ranjan Dasmunsi said after the Cabinet meting.
The merger will create and fill upto 13 restructured additional posts in the IPC in liew of 38 vacant posts in CIPL which would be abolished simultaneously.
The post of Director, CIPL will be upgraded from the scale of Rs 14300-18300 to Rs 18400-22400 so as to function as the Secretary-cum-Scientific Director of the IPC.
The move will help the test protocols of drugs included in IP to ge updated regularly by periodic review of Indian Pharmacopoeia.
This would also help foreign exchange savings by using IP reference substances and better acceptance of Indian drugs in the international market.
UNI RT BJR DB1952